Abbott Laboratories · NYSE:ABT
The Vanguard Group reported a 10.05% stake in Abbott Laboratories (Schedule 13G/A)
Event Nov 28, 2025 · Filed Dec 3, 2025
The Vanguard Group reported a 10.05% stake in Abbott Laboratories, 174,894,079 shares, as a passive investor on Nov 28, 2025. Filed Dec 3, 2025 (Schedule 13G/A).
- Stake
- 10.05%
- Shares
- 174,894,079
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.05% | 174,894,079 |
Source
Related
- Abbott Laboratories
- The Vanguard Group
- Abbott Laboratories shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Conroy Kevin T · Sep 25, 2026
- Form 4 · McCoy John A. Jr. · Sep 3, 2026
- Form 4 · Boudreau Philip P · Sep 3, 2026
- Form 4 · Ford Robert B · Aug 27, 2026
- Form 4 · Morrone Louis H. · Aug 13, 2026